This article was originally published in The Gray Sheet
Minnesota federal judge dismisses suit against the firm and founder Timothy Lawin Sept. 30. Brought by Uroplasty in August 1998, the suit alleged that Lawin had misappropriated Uroplasty's pyrolytic, carbon-coated micro-bead technology for use in the Durasphere injectable stress urinary incontinence product. Durasphere was approved by FDA Sept. 13 (1"The Gray Sheet" Sept. 27, p. 14). U.S. district court Judge Michael Davis rules that Uroplasty failed to show evidence that the firm was ever involved with the development of the technology
You may also be interested in...
Advanced UroScience's post-approval study of its Durasphere bulking agent for treatment of female stress urinary incontinence due to intrinsic sphincter deficiency will focus on evaluating the durability of the product, the company reports.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.